Engerix-b 20 MCG/ML syrnml
Ended Awarded Last action
- Contract number
- SPE2DR26FXVL4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,758
Award facts
- Contract value 100% obligated
- $2,757.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 27, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,757.64 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML (hepatitis B vaccine) with an ultimate completion date of January 28, 2026. The contract was awarded on a firm fixed-price basis with no set-aside designation, indicating competitive award to the most qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee, while its parent company Cencora, Inc. (doing business as AmerisourceBergen) holds the underlying indefinite delivery contract vehicle.
This delivery order is issued under Cencora's substantial $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally through December 2026. The contract encompasses a comprehensive range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in fulfilling government medical procurement requirements, with consistent delivery of critical pharmaceuticals and vaccines to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FXVL4?
SPE2DR26FXVL4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FXVL4 worth?
The government has obligated $2,758 on SPE2DR26FXVL4.
Is contract SPE2DR26FXVL4 an order under another contract?
Yes. SPE2DR26FXVL4 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXVL4 competed?
The extent of competition for SPE2DR26FXVL4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award